Effects of Therapeutic Doses of Acetaminophen in Moderate Drinkers
Information source: Denver Health and Hospital Authority
Information obtained from ClinicalTrials.gov on June 20, 2008 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Moderate Alcohol Consumption (1-3 Drinks Per Day)
Intervention: acetaminophen (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Denver Health and Hospital Authority Official(s) and/or principal investigator(s): Kennon Heard, MD, Principal Investigator, Affiliation: Rocky Mountain Poison Center
Summary
The study objective was to evaluate the safety of ten consecutive days of therapeutic
acetaminophen dosing in moderate alcohol consumers. The main outcome was liver injury
(measured by an increase in mean serum ALT or AST levels). Patients were randomly assigned
to 10 days of acetaminophen or placebo. Blood tests were measured at baseline, day 4 and day
11 to look for injury. We hypothesized that there would be no difference in liver enzymes
between the two groups.
Clinical Details
Official title: Assessment of Hepatic Injury in Subjects Who Consume Moderate Amounts of Alcohol While Being Administered Therapeutic Doses of Acetaminophen:
Study design: Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety Study
Primary outcome: mean change in serum ALT between treatment groups
Secondary outcome: proportion of patients that developed an abnormal ALTproportion of patients that developed hepatoxicity (ALT>1000 IU>L) proportion of patients that developed drug induced liver injury
Eligibility
Minimum age: 21 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion criteria Adult volunteers of age 21 years or older, regardless of ethnicity or
gender, who provided written consent and met all three of the following criteria of a
moderate alcohol consumer:
1. Average baseline ethanol consumption of at least one alcoholic beverage per day before
enrollment for the past two months. The estimate of ethanol intake was based on the
average intake over seven days. For example, a person who ingested no alcohol on
Sunday, Monday, Tuesday or Wednesday, two drinks on Thursday and four drinks on Friday
and Saturday would be calculated as 10 drinks/7days = 1. 4 drinks/day. The average
alcoholic beverage contains 15 grams of alcohol(9).
2. Average baseline ethanol consumption of no more than three alcoholic beverages (> 45
grams of alcohol) per day, calculated as a weekly average over the preceding two
months.
3. At least one alcohol-containing drink within the last 48 hours
Exclusion Criteria
Subjects were excluded from the study at baseline if any of the following were evident at
baseline:
1. Serum acetaminophen level greater than 20 mcg/ml
2. Serum AST or ALT levels greater than 50 IU/L
3. If female, positive for b-HCG
4. Clinically intoxicated, psychiatrically impaired or unable to give informed consent
5. Known hypersensitivity to acetaminophen
6. History of ingesting more than four grams of acetaminophen per day for any of the four
days preceding study enrollment
7. Alcoholic patients as defined by those who consume on average more than three
alcoholic beverages daily
8. Currently enrolled in another trial or had been enrolled in another trial in the
preceding three months
Locations and Contacts
Additional Information
Starting date: April 2003
Ending date: September 2003
Last updated: November 16, 2006
|